Stanford University Medical Center's Dr Oliver Dorigo presents a step-by-step guide to making decisions around ovarian cancer.
Welcome to Stanford University Medical Center’s Dr Oliver Dorigo’s digital prescription for helping to make decisions around ovarian cancer.
Dr Oliver Dorigo is one of the leading experts in his field. People in the ovarian cancer community tell us that hearing his advice has helped them to make better decisions and reduce anxiety.
If someone you know could benefit from this guide, please share a link
Dr. Oliver Dorigo
You may be feeling fear of ovarian cancer after a diagnosis. We hope SurvivorNet can help you deal with your emotions and focus on the journey ahead.
Dr. Oliver Dorigo, an oncologist at Stanford Medical School, explains some of the new testing methods that can guide ovarian cancer treatment.
Olaparib is currently being tested in a clinical trial, the SOLO1 trial, as a front-line therapy for the prevention of recurrence in ovarian cancer.
The drug Bevacizumab, or Avastin, can be an effective treatment for various stages of ovarian cancer, particularly for high-risk cases.
PARP inhibitors are a relatively new class of drugs used in the maintenance phase for ovarian cancer patients. They work by blocking DNA repair.
There are three types of PARP inhibitors: Niraparib, Olaparib, Rucaparib. They have very similar efficacies, but each drug has different side effects.
Women with ovarian cancer can develop resistance to Platinum-based chemo drugs, the most common and effective class of drugs.
PARP inhibitors are effective following initial surgery and chemotherapy for ovarian cancer patients, especially for patients with a BRCA mutation.
There are three types of PARP inhibitors. Ultimately, which PARP inhibitor is best will come down to a discussion with your physician.
Our newsletter – vital information, hope, and healing, delivered weekly.
Use this bar to access information about the steps in your cancer journey.
Please sign in to save videos. Don't have an account? Register
Username or email address *
Lost your password?
Not a member yet? Register now.